Lung cancer is the leading cause of cancer death in the United States for men and women, with an estimated 127 070 deaths from lung cancer occurring in the United States in 2023 (1). Lung cancer screening has been recommended by the US Preventive Services Task Force (USPSTF) since 2013, based on evidence from the National Lung Screening Trial (NLST), which showed that 3 annual low-dose computed tomography (CT) screens reduced 5-year lung cancer mortality by 20% (2).